Skip to main content
Enovis Corporation (ENOV)
NYSE: ENOV · Real-Time Price · USD
27.02
-0.94 (-3.36%)
Dec 5, 2025, 4:00 PM EST - Market closed

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
 Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
United States Revenue
1.30B1.25B
Log In
Log In
Log In
Upgrade
Foreign Locations Revenue
931.71M861.95M
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.23B2.11B
Log In
Log In
Log In
Upgrade

Revenue

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
 Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
U.S. Bracing & Support Revenue
487.10M469.32M
Log In
Log In
Log In
Upgrade
U.S. Other P&R Revenue
279.10M270.74M
Log In
Log In
Log In
Upgrade
International P&R Revenue
374.84M357.90M
Log In
Log In
Log In
Upgrade
Total Prevention & Recovery Revenue
1.14B1.10B
Log In
Log In
Log In
Upgrade
U.S. Reconstructive Revenue
535.36M505.62M
Log In
Log In
Log In
Upgrade
International Reconstructive Revenue
556.87M504.05M
Log In
Log In
Log In
Upgrade
Total Reconstructive Revenue
1.09B1.01B
Log In
Log In
Log In
Upgrade
Total Medical Technology Revenue
2.23B2.11B
Log In
Log In
Log In
Upgrade
Revenue (Other)
-2.23B-2.11B
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.23B2.11B
Log In
Log In
Log In
Upgrade

Adjusted EBITDA

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
 Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
Prevention & Recovery Adjusted EBITDA
167.69M159.60M
Log In
Log In
Log In
Upgrade
Reconstructive Adjusted EBITDA
236.27M216.92M
Log In
Log In
Log In
Upgrade
Operating Income (Other)
-1.69B-1.15B
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-1.29B-775.72M
Log In
Log In
Log In
Upgrade

Capital Expenditures

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2019
Prevention & Recovery Capital Expenditures
34.00M
Log In
Log In
Log In
Upgrade
Reconstructive Capital Expenditures
146.71M
Log In
Log In
Log In
Upgrade
Total Medical Technology Capital Expenditures
180.71M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Fiscal year is January - December.
Year Ending
 NaN - NaN